| Carnitine and acylcarnitines SE Reuter, AM Evans Clinical pharmacokinetics 51 (9), 553-572, 2012 | 174 | 2012 |
| Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease AM Evans, RJ Faull, RL Nation, S Prasad, T Elias, SE Reuter, G Fornasini Kidney international 66 (4), 1527-1534, 2004 | 60 | 2004 |
| Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients SE Reuter, RJ Faull, E Ranieri, AM Evans Nephrology Dialysis Transplantation 24 (3), 990-996, 2008 | 53 | 2008 |
| Reliability and validity of indices of hand‐grip strength and endurance SE Reuter, N Massy‐Westropp, AM Evans Australian occupational therapy journal 58 (2), 82-87, 2011 | 49 | 2011 |
| L‐carnitine supplementation in the dialysis population: Are Australian patients missing out? SE Reuter, RJ Faull, AM Evans Nephrology 13 (1), 3-16, 2008 | 40 | 2008 |
| Determination of the reference range of endogenous plasma carnitines in healthy adults SE Reuter, AM Evans, DH Chace, G Fornasini Annals of clinical biochemistry 45 (6), 585-592, 2008 | 38 | 2008 |
| Long‐chain acylcarnitine deficiency in patients with chronic fatigue syndrome. Potential involvement of altered carnitine palmitoyltransferase‐I activity SE Reuter, AM Evans Journal of internal medicine 270 (1), 76-84, 2011 | 30 | 2011 |
| Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease SE Reuter, AM Evans, RJ Faull, DH Chace, G Fornasini Annals of clinical biochemistry 42 (5), 387-393, 2005 | 29 | 2005 |
| Pharmacokinetics of cannabis in cancer cachexia-anorexia syndrome SE Reuter, JH Martin Clinical pharmacokinetics 55 (7), 807-812, 2016 | 24 | 2016 |
| Effect of food on the pharmacokinetics of piperaquine and dihydroartemisinin SE Reuter, AM Evans, S Shakib, Y Lungershausen, B Francis, G Valentini, ... Clinical drug investigation 35 (9), 559-567, 2015 | 18 | 2015 |
| Population pharmacokinetics of orally administered mefloquine in healthy volunteers and patients with uncomplicated Plasmodium falciparum malaria SE Reuter, RN Upton, AM Evans, V Navaratnam, PL Olliaro Journal of Antimicrobial Chemotherapy 70 (3), 868-876, 2014 | 14 | 2014 |
| Pharmacokinetics and Comparative Bioavailability of Artesunate and Me. oquine Administered Separately or as a Fixed Combination Product to Healthy Volunteers and Patients with … P Olliaro, S Ramanathan, M Vaillant, SE Reuter, AM Evans Malaria. J Bioequiv Availab 2, 059-066, 2010 | 11 | 2010 |
| Cannabinoid Disposition After Human Intraperitoneal Use: AnInsight Into Intraperitoneal Pharmacokinetic Properties in Metastatic Cancer CJ Lucas, P Galettis, S Song, N Solowij, SE Reuter, J Schneider, ... Clinical therapeutics 40 (9), 1442-1447, 2018 | 7 | 2018 |
| Pharmacokinetics of a transdermal testosterone cream in healthy postmenopausal women E Fooladi, SE Reuter, RJ Bell, PJ Robinson, SR Davis Menopause 22 (1), 44-49, 2015 | 7 | 2015 |
| Population pharmacokinetics of lenalidomide in patients with B‐cell malignancies JH Hughes, MA Phelps, RN Upton, SE Reuter, Y Gao, JC Byrd, ... British journal of clinical pharmacology 85 (5), 924-934, 2019 | 2 | 2019 |
| How ‘optimal’are optimal sampling times for tyrosine kinase inhibitors in cancer? Practical considerations MB Ward, SE Reuter, JH Martin Clinical pharmacokinetics 55 (10), 1171-1177, 2016 | 2 | 2016 |
| Perceived and actual paracetamol dosing in overweight and obese children MD Wiese, JK Sluggett, CJ Wilson, SE Reuter, SC Turner, AM Evans European Journal of Hospital Pharmacy: Science and Practice 19 (5), 438-442, 2012 | 2 | 2012 |
| Reducing palivizumab dose requirements through rational dose regimen design SE Reuter, AM Evans, MB Ward CPT: pharmacometrics & systems pharmacology 8 (1), 26-33, 2019 | 1 | 2019 |
| Population pharmacokinetics of ribavirin in lung transplant recipients and examination of current and alternative dosing regimens E Milliken, AES de Zwart, JWC Alffenaar, DJE Marriott, ... Journal of Antimicrobial Chemotherapy 74 (3), 691-698, 2018 | 1 | 2018 |
| What is the value of l‐carnitine level determination for carnitine supplementation in hemodialysis patients? SE Reuter, AM Evans Hemodialysis International 17 (3), 335-338, 2013 | 1 | 2013 |
